FindTrial
Sign In

Prediction of recurrence of multiple sclerosis using medical imaging

Early prediction of multiple sclerosis recurrence using multimodal neuroimaging: a clinical research

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000037006
Enrollment
Unknown
Registered
2020-08-26
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

multiple sclerosis

Interventions

Recurrence Group:Treatment in acute phase
Stable group:Disease modification therapy

Sponsors

Huashan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) They were 18-65 years old, and the diagnosis met the McDonald's criteria revised in 2017; 2) There was no significant change in EDSS score within 6 months after the onset of the disease or in the stable stage, more than 1 month after the last attack; 3) MRI examination sequence was complete: baseline and multimodal MRI examination at 6 months, 1 year and 2 years; 4) Sign informed consent.

Exclusion criteria

Exclusion criteria: 1) The course of disease was more than 30 years; 2) History of brain injury or spinal cord injury; 3) History of CNS infection or immunodeficiency syndrome; 4) HBV, HCV, syphilis, HIV-1, HIV-2 patients; 5) Suffering from mental illness; 6) Pregnant and lactating women or patients planning to conceive within one year; 7) The patients also participated in other randomized controlled clinical trials.

Design outcomes

Primary

MeasureTime frame
enhanced lesions on Flair;paramagnetic rims;Cortical thickness;—

Countries

China

Contacts

Public ContactLi Haiqing

Huashan Hospital, Fudan University

lihaiqing@fudan.edu.cn+86 13761790210

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026